Tumor Virology Research
The Tumor Virology Program of the Cancer Center was initated by Dr. James Alwine in 1993 in an attempt to bring virologists from different programs and departments within the University of Pennsylvania together to stimulate interactions and discussions. An increase in the need for this program became evident with the more recent discovery that Kaposi's sarcoma associated herpesvirus (KSHV/HHV-8) was strongly associated with greater than 50% of head and neck squamous cell carcinomas. Research on tumor viruses is linked by studies elucidating the role of specific viruses as an essential requirement or as a critical cofacctor in the development of human cancers. Research on tumor viruses at Penn includes investigators from the Medical School, Dental School and the Wistar Institute studying the basic mechanisms of tumorigenesis, clinical implications of tumor viruses and translational approaches to the development of therapies for the treatment of virus associated human cancers.
Tumor Virology Researchers at the University of Pennsylvania
© The Trustees of the University of Pennsylvania | Site best viewed in a supported browser. | Site Design: PMACS Web Team